Graduate Student Veronica Hubble Receives Travel Award

Author: Rebecca Hicks


Veronica Hubble, a fourth-year graduate student in the lab of Christian Melander, George & Winifred Clark Professor, is the recipient of a 2019 American Chemical Society Women Chemists Committee (WCC)/Eli Lilly Travel Award. This travel award provides funding to attend scientific meetings; Hubble will be traveling to the 2019 ACS National Meeting in Orlando, FL.  Along with travel support, award winners present at a special poster session, attend a winner’s reception, and are invited to a WCC luncheon and a WCC dinner at the ACS meeting.…

Read More

8th Annual HCRI Cancer Research Day

Author: Rebecca Hicks

Please join us at HCRI's 8th Annual Cancer Research Day! 

Research Day is an excellent opportunity to learn about cancer research being conducted in our community. This event includes a poster session, lectures, and a Keynote Address.

Read More

Students may apply for a “trip of a lifetime” in the Galápagos Islands

Author: Colleen Wilcox

Domewithclouds 250

Students are invited to compete and apply for a trip to the Galápagos Islands to trace steps that Charles Darwin took on his path to discovery. The week-long trip takes place August 3-9 and is open to Notre Dame undergraduates (rising juniors or rising seniors) in any field of study. Applications are due February 1.

Read More

The Naturalist: Rev. Julius A. Nieuwland, CSC

Author: Deanna Csomo McCool

Chemistry was a fine preoccupation for the Holy Cross priest whose research yielded numerous explosions and the smelly, oily marrow of synthetic rubber. But Julius Nieuwland’s first love was botany.

Read More

Burns appointed as honorary professor at top Chinese university

Author: Allison Preston

Peter Burns 250

Peter Burns, Henry J. Massman professor, concurrent professor in the Department of Chemistry and Biochemistry, and director of the Center for Sustainable Energy and director of the Actinide Center of Excellence, was appointed as an Honorary Professor at Xi’an Jiaotong University in China.

Read More

New study reveals surprising effects of mutations in proteins

Author: Teresa L. Johnson

Jeff Peng

Predicting how mutations in proteins alter their ability to function is critical to understanding what drives health and disease in humans. A new study in Structure, Cell Press by scientists at the University of Notre Dame and their colleagues demonstrates how a minor mutation can have far-reaching effects on a protein, playing a role in the onset of different diseases.

Read More

Study uncovers new hurdle for developing immunotherapies

Author: Deanna Csomo McCool

The body’s immune system is a valiant weapon against disease, and harnessing its power through a technique called immunotherapy is at the forefront of current research to treat cancer and other diseases. That’s why an unexpected finding by Notre Dame researchers and their collaborators, related to the way two distinctively different peptide antigens react with one T-cell receptor, tosses a new wrench into the process of building better molecules to develop immunotherapies.

Read More

University of Notre Dame to host Indiana CTSI retreat

Author: Brandi Klingerman


Indiana University, Purdue University, and the University of Notre Dame invite all researchers to attend the Indiana Clinical and Translational Sciences Institute (CTSI) retreat. The event will take place at the University of Notre Dame’s McCourtney Hall on Friday, October 26, 2018 from 9:00 a.m. to 4:15 p.m.

Read More

Biophysicist awarded $1.1 million NIH grant to study role of protein dynamics in antibiotic resistance

Author: Cheryl Schairer

Jeff W. Peng

The β-lactams are a vast family of antibiotics that include the well-known penicillins; they remain the most widely administered antibiotics around the globe.  Results from the research of Jeff W. Peng, associate professor of chemistry and biochemistry, could reveal new strategies for coping with the expanding scope of β-lactam resistance now happening among Gram-negative pathogens.

Read More

Notre Dame startup Structured Immunity and Medigene announce collaboration aimed at improving T cell receptor development

Author: Nick Swisher

Structured Immunity, a Notre Dame startup and biotechnology company specializing in the optimization and validation of T cell receptor (TCR) proteins, and Medigene AG, a leading biotechnology company engaged in the development of immunotherapies for the treatment of cancer, today announced a research collaboration where Structured Immunity will provide structural immunology expertise in support of Medigene’s TCR discovery activities.


Read More